Vizora日本語

JCR PharmaceuticalsJCR Pharmaceuticals Co.,Ltd.4552東証プライム医薬品FY ending Mar 2026, consolidated, J-GAAP

JCR Pharmaceuticals FY ending Mar 2024 results

JCR Pharmaceuticals brought in ¥42.9B in revenue.

Out of every ¥100 of sales, about ¥18 is left as operating profit.

Revenue changed +24.8% from the prior year, operating profit +51.4%.

Revenue and profit pattern

Revenue and profit upProfit grew faster

Revenue +24.8% · profit +51.4%, calculated from disclosed figures.

Operating leverage: 2.07× (profit growth ÷ revenue growth)

What changed from last year

FY ending Mar 2023 → FY ending Mar 2024

Revenue
+24.8%¥34.3B → ¥42.9B
Gross profit
+22.8%¥25.5B → ¥31.3B
Operating income
+51.4%¥4.97B → ¥7.53B
Net income attributable to owners
+46.0%¥3.77B → ¥5.51B
Operating cash flow
Back to profit-¥5.5B → ¥9.31B
Free cash flow
Back to profit-¥14.1B → ¥7.79B

Where the money goes

FY ending Mar 2023 → FY ending Mar 2024

Where ¥100 of sales goes

For every ¥100 JCR Pharmaceuticals sells, how much goes where, and how much is kept.

FY ending Mar 2024
Cost of sales
¥27
SG&A
¥55
Operating profit
¥18
Net profit kept
¥13

Annual margin trends

Gross margin72.9%
FY ending Mar 2020: 68.1%68.1%FY ending Mar 2021: 74.0%74.0%FY ending Mar 2022: 79.5%79.5%FY ending Mar 2023: 74.1%74.1%FY ending Mar 2024: 72.9%72.9%FY20FY21FY22FY23FY24
Operating margin17.6%
FY ending Mar 2020: 13.1%13.1%FY ending Mar 2021: 27.5%27.5%FY ending Mar 2022: 39.0%39.0%FY ending Mar 2023: 14.5%14.5%FY ending Mar 2024: 17.6%17.6%FY20FY21FY22FY23FY24
Net margin12.8%
FY ending Mar 2020: 10.8%10.8%FY ending Mar 2021: 22.9%22.9%FY ending Mar 2022: 28.4%28.4%FY ending Mar 2023: 11.0%11.0%FY ending Mar 2024: 12.8%12.8%FY20FY21FY22FY23FY24

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    訂正有価証券報告書－第51期(2025/04/01－2026/03/31)

    ID S100YSOS2026-07-29Open

  • EDINET (FSA Japan)

    有価証券報告書－第50期(2024/04/01－2025/03/31)

    ID S100W3Q52025-06-25Open

  • EDINET (FSA Japan)

    有価証券報告書－第49期(2023/04/01－2024/03/31)

    ID S100TQM62024-06-26Open

  • EDINET (FSA Japan)

    訂正有価証券報告書－第48期(2022/04/01－2023/03/31)

    ID S100SNAG2024-01-19Open

  • EDINET (FSA Japan)

    有価証券報告書－第47期(令和3年4月1日－令和4年3月31日)

    ID S100OAJT2022-06-22Open

  • EDINET (FSA Japan)

    有価証券報告書－第46期(令和2年4月1日－令和3年3月31日)

    ID S100LL7F2021-06-23Open

Extracted from XBRL: 53 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image